Synthetic cornea offers new hope for the untreatably blind
NCT ID NCT05694247
Summary
This study is testing a new artificial cornea for people who are blind due to corneal disease and cannot receive a standard corneal transplant. The device will be surgically implanted in 40 participants, who will then be closely monitored for safety and vision improvement over two years. The goal is to restore vision in cases where other treatments have failed or are not an option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL OPACITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC - Location AMC
Amsterdam, 1105 AZ, Netherlands
-
CHU de Montpellier
Montpellier, 34295, France
-
Hopital Fondation Adolphe de Rothschild
Paris, France
-
Rabin Medical Center - Beilinson
Petah Tikva, Israel, 4941492, Israel
-
UHN - University Health Network
Toronto, Ontario, M5T 2S8, Canada
-
University of British Columbia
Vancouver, British Columbia, V5Z 3N9, Canada
Conditions
Explore the condition pages connected to this study.